Results

Caveolin-1 Expression Increases After Monocyte Differentiation into Macrophage
THP-1 monocytes can be activated and differentiated into macrophages by phorbol myristate acetate (PMA), and it is widely applied as a cell model for studies on monocyte differentiation. [16] [17] [18] In the current study, THP-1 monocytes were treated with PMA in time-and dose-dependent patterns. Caveolin-1 expression was shown to increase by Western blot ( Figure IA and IB in the online-only Data Supplement) after PMA treatment. To confirm that THP-1 cells were activated and differentiated by PMA, the macrophage marker CD68 was assessed by flow cytometry and confirmed to increase with PMA 100 nmol/L at 72 hours ( Figure IC in the onlineonly Data Supplement).
To validate that the findings from the immortalized THP-1 cells were also true of primary cells, human and mouse primary monocytes were stimulated to differentiate. Caveolin-1 expression was increased by M-CSF treatment ( Figure 1A) , and CD68 was likewise elevated confirming the differentiation of human primary monocytes to macrophages ( Figure ID in the onlineonly Data Supplement). Likewise, mouse peripheral blood mononuclear cells stimulated by granulocyte-macrophage CSF (GM-CSF) demonstrated an increase in caveolin-1 and CD68 by real-time polymerase chain reaction ( Figure 1B) . Although it has been reported that peripheral blood mononuclear cells rarely express caveolin-1 with the exception of those cells in the monocyte/macrophage lineage, 19, 20 the caveolin-1 expression detected in these studies may be construed to be relevant to this lineage. Moreover, flow analysis displayed the decrease of monocyte marker ly6C and increase of macrophage markers, CD115 and F4/80 on CD11b+ peripheral blood mononuclear cells, indicating mouse monocyte differentiation into macrophage ( Figure IE in the online-only Data Supplement). These experiments demonstrate that the expression of caveolin-1 was elevated after monocyte to macrophage differentiation in both immortalized and primary cells.
Increasing Caveolin-1 in THP-1 Monocytes Promotes Differentiation into Macrophages
To examine whether caveolin-1 can promote the differentiation of monocytes into macrophages, we increased caveolin-1 expression in THP-1 cells by transfection with pcDNA3caveolin-1 expression plasmid or pcDNA3 as control using Western blots to confirm transfection efficiency ( Figure IIA in the online-only Data Supplement). Monocyte inflammatory and differentiation gene expression levels were then assessed by real-time polymerase chain reaction. Caveolin-1 transfection significantly increased the expression of the inflammatory genes, CD11b and intercellular cell adhesion molecule-1 ( Figure IIB in the online-only Data Supplement), as well as those of the macrophage markers CD68 and CD36 ( Figure 2A ). As expected, application of the positive control PMA induced increased expression of these genes ( 
Knockdown of Caveolin-1 Inhibits Monocyte to Macrophage Differentiation
To further explore the role of caveolin-1 in PMA-induced monocyte differentiation, THP-1 monocytes were transfected with control or caveolin-1 small interfering RNA plasmids and then treated with PMA at 100 nmol/L for 72 hours. The knockdown of caveolin-1 was confirmed by Western blot. Whereas untreated cells did not display a significant knockdown of caveolin-1 because of the low basal level of expression ( Figure  IIC in the online-only Data Supplement), caveolin-1 knockdown decreased PMA-induced monocyte inflammatory ( Figure IID in the online-only Data Supplement, CD11b and intercellular cell adhesion molecule-1) and differentiation ( Figure 2B : CD68, CD36, and CD14) gene expression. The finding was validated in mouse primary cells where peripheral blood mononuclear cells from wild-type (WT) and caveolin-1 knockout (KO) mice were induced to differentiate by GM-CSF. The morphology of the differentiated cells from 2 different mouse types displayed a significant difference, that is, a more elongated phenotype in the WT group as compared with the rounded appearance of the KO group ( Figure 2C ). Moreover, the GM-CSF-induced CD68 expression was inhibited in KO cells compared with WT cells using real-time polymerase chain reaction ( Figure  2D ). Similarly, flow analysis showed the GM-CSF-induced macrophage markers CD115 and F4/80 in KO CD11b + Figure 1 . The expression of caveolin-1 is increased after monocyte differentiation. A, Human primary monocytes were treated with human macrophage colony-stimulating factor (M-CSF) (50 ng/mL) for 7 days. Caveolin-1 and GAPDH in untreated (C) and M-CSF-treated (M) cells were detected by western blot. B, Mouse peripheral blood mononuclear cells (PBMCs) were treated with mouse granulocyte-macrophage CSF (GM-CSF) (50 ng/mL) for 7 days. The gene expressions of caveolin-1 (Cav-1) and CD68 were measured by real-time polymerase chain reaction. Graph shows the relative quantitative ratios of target genes to 18S, and the ratios are set as 1 in control groups. Data are from 3 independent experiments (*P<0.05 vs control group).
cells were decreased compared with the WT group ( Figure 2E ). These results further emphasize the critical role of caveolin-1 in monocyte to macrophage differentiation.
Nucleus Location of EGR-1 and Its Target Genes Are Regulated by Caveolin-1 Expression During Monocyte Differentiation into Macrophage
Several transcription factors have been reported to be involved in monocyte differentiation and macrophage maturation. 15, 21 Among these, EGR-1 transcription activity has been demonstrated to be inhibited by caveolin-1 knockdown in fibroblasts. 13 We, therefore, hypothesized that caveolin-1 influenced monocyte differentiation into macrophage through regulation of EGR-1 transcriptional activity.
THP-1 monocytes were transfected with control or caveolin-1 small interfering RNA plasmids, and then treated with PMA (100 nmol/L) for 72 hours. PMA increased the expression of EGR-1, and although caveolin-1 knockdown did not affect the PMA-induced EGR-1 expression in whole cell fraction, it inhibited its nuclear location ( Figure 3A ). Moreover, decreasing caveolin-1 expression also blocked PMA-induced extracellular signal-related kinase (ERK) phosphorylation ( Figure 3A ), which was related to EGR-1 nuclear translocation. 22 Pretreatment with U0126, the mitogen-activated protein ERK kinase 1/2 inhibitor, inhibited the PMA-induced ERK phosphorylation and nuclear translocation of EGR-1 but had no effect on caveolin-1 expression ( Figure III in the online-only Data Supplement). These results indicated that caveolin-1 affects monocyte differentiation through ERK phosphorylation and the nuclear translocation of EGR-1. Because CD115 and tumor necrosis factor-α are target genes of EGR-1 in monocyte to macrophage differentiation, we explored their expression levels and showed that both were elevated after PMA-induced monocyte differentiation into macrophage but inhibited by knockdown of caveolin-1 ( Figure  3B ). To further explore the effect of caveolin-1 on EGR-1 and its target genes during differentiation, EGR-1 DNA-binding ability was assessed using chromatin immunoprecipitation assay. PMA increased the binding of EGR-1 to its target sequence on CD115 promoter but this was inhibited by caveolin-1 knockdown ( Figure 3C ). These results demonstrate that inhibition of nuclear translocation of EGR-1 by caveolin-1 knockdown further decreases the binding of EGR-1 to its target promoter sequence inhibiting its transcription efficiency.
Caveolin-1 Regulates the Physiological Functions of Monocyte and Macrophage
Migration and phagocytosis are 2 major functions of monocyte/macrophage cells. Here, we explore the influence of . Inhibition of caveolin-1 (CAV-1) expression decreases the nuclear location of early growth response 1 (EGR-1) and its target genes expression. A, THP-1 cells were transfected with pcDNA6.2-GW/EmGFP-control-miR (ctrl) or pcDNA6.2-GW/EmGFP-caveolin-1-miR (CAV). The transfected cells were then treated with vehicle or phorbol myristate acetate (PMA) (100 nmol/L) for 72 hours. The proteins in nuclear fraction (NP) and whole cell lysate (WCL) were applied for Western blot to detect EGR-1, phosphorylated extracellular signal-related kinase (pERK), total ERK (t-ERK), caveolin-1, and β-tubulin. Bar graphs show the ratios of EGR-1 or caveolin-1 to β-tubulin in WCL, EGR-1 in NP to WLC, and pERK to total ERK, respectively (*P<0.05; n=4). B and C, RNAi plasmids-transfected THP-1 cells were treated with PMA (100 nmol/L) for 72 hours. B, EGR-1 target genes were detected by real-time polymerase chain reaction. Graph shows the relative quantitative ratios of target genes to 18S, and control groups are set as 1. Data were from 3 independent experiments (*P<0.05). C, Graph shows the relative quantitative ratio of EGR-1 binding sequence of CD115 promoter in precipitated group to input group, and anti-EGR-1 antibody precipitated group under control condition is set as 1. Rabbit IgG was applied to exclude the nonspecific antibody binding (*P<0.05; n=3). siRNA indicates small interfering RNA; TNF-α tumor necrosis factor-α, DMSO, dimethyl sulfoxide;
caveolin-1 in transmigration ( Figure 4A ) and phagocytosis ( Figure 4B ) of monocytes/macrophages. In nontransfected cells, PMA-treated cells (macrophages) displayed lower transmigration and higher phagocytosis abilities than untreated cells (monocytes), consistent with the macrophage phenotypes expected. Caveolin-1 overexpression inhibited transmigration and promoted the phagocytosis in untreated THP-1 cells, whereas knockdown of caveolin-1 inhibited the phagocytosis without effect on transmigration in PMA-induced cells. These results demonstrate that caveolin-1 is positively associated with phagocytosis, a macrophage function, and negatively with transmigration, a monocytic function.
In atherosclerosis, monocyte-derived macrophages form foam cells through the uptake of modified low-density lipoprotein (LDL). Here, we measured the ability of acetylated LDL endocytosis on both THP-1 monocytic cells and mouse macrophages. As shown in Figure 4C (including Figure IVA in the online-only Data Supplement), PMA-treated THP-1 cells (macrophages) display more acetylated LDL uptake than untreated THP-1 monocytes, which was inhibited by caveolin-1 knockdown, consistent with the findings in the phagocytosis assay. WT mouse peritoneal macrophages took up more acetylated LDL than cells from KO mice ( Figure 4D ; and Figure  IVB in the online-only Data Supplement). These experiments indicate that caveolin-1 plays a critical role in the modified LDL endocytosis of macrophages to form foam cells. To further explore the role of caveolin-1 in macrophage-derived foam cell formation, LDL-treated mouse peritoneal macrophages were collected for lipid extraction and determination. As expected, LDL treatment increased cholesteryl ester and triglyceride content (2 of the major lipid species in foam cells) in macrophages. Caveolin-1 KO cells displayed significantly less lipid content in comparison ( Figure 4E-4F) implying that decreasing caveolin-1 reduces foam cell formation.
Monocyte Differentiation to Macrophage Decreases in Caveolin-1 KO Mice
To confirm the influence of caveolin-1 in monocyte to macrophage differentiation in vivo, caveolin-1 KO mice were used. At baseline, there are significantly less CD115 + / CD11b + cells as a decreased precentage of all peritoneal cells After a 4-hour incubation, the uptake of beads by cells was detected by flow cytometry. Graph shows the group data of FITC geo-means under different conditions. Data are from 4 independent experiments (*P<0.05). C, THP-1 cells were transfected with control small interfering RNA (siRNA) or caveolin-1 siRNA, and then treated with vehicle or PMA (100 nmol/L) for 72 hours. D, Peritoneal macrophages were isolated from wild-type (WT) and caveolin-1 KO (KO) mice. C and D, DiI-acetylated lowdensity lipoprotein (LDL; 10 µg/mL) was added to treated cells for 24 hours. Graphs are group data of DiI fluorescence intensities, and the intensities of PMA-treated THP-1 cells with control siRNA (C) and WT macrophages (D) are set as 100% (*P<0.05; n=3). E and F, PMA-(2 nmol/L) activated mouse peritoneal macrophages were treated with or without LDL (50 µg/mL) for 24 hours. Lipids content of treated cells were extracted and determined for cholesterol esters (CEs) (E) and triglycerides (TGs) (F). Graphs show the amount of all CEs and top 10 abundant TGs in treated cells (*P<0.05; n=3). KO indicates knockout.
in caveolin-1 KO mice compared with WT (WT 55% versus KO 39%). However, there is no difference in the number of F4/80 + /CD11b + cells between WT and KO mice. When mice were administered 2.9% thioglycollate, the quantity of macrophages, including CD115 + /CD11b + (basally 55%) and F4/80 + /CD11b + (basally 27%) cells in the peritoneal cavity, was increased (CD115 69% versus F4/80 66%) in WT mice. However, no significant elevation of these cells was found in KO animals ( Figure 5A ) demonstrating that reduced monocyte to macrophage differentiation in the peritoneal cavity occurs in vivo in mice lacking caveolin-1 in response to inflammatory stimulation, implying that KO of caveolin-1 delays or inhibits differentiation. As peritoneal macrophages are derived from monocytes in the blood and bone marrow, we measured the levels of CD11b + and ly6C + cells (monocytes) from both these sources. Consistent with the low conversion of monocytes to macrophages observed in the peritoneal cavity, we observed higher levels of blood monocytes in KO mice than WT (WT 11% versus KO 19%). In addition, thioglycollate injection, which had no influence on the differentiation of monocytes to macrophages in KO animals, did not influence blood monocyte levels (WT 12% versus KO 19%; Figure VA in the online-only Data Supplement). WT mice were observed to have higher levels of bone marrow-derived monocytes than KO animals (WT 54% versus KO 48%). This may be because of the demand to replenish peripheral monocytes in these animals. After thioglycollate injection, a fall in bone marrow monocytes was observed possibly because of immediate mobilization of these cells into the periphery (WT 48% versus KO 57%; Figure VB in the online-only Data Supplement).
To validate the influence of caveolin-1 on ERK phosphorylation and EGR-1 nuclear translocation in vivo, we showed using Western blot that peritoneal cells from KO mice displayed reduced ERK phosphorylation and nuclear location of EGR-1 compared with WT cells ( Figure 5B ). Moreover, chromatin immunoprecipitation analysis also showed that caveolin-1 KO decreases the EGR-1 binding to its target site on CD115 promoter in peritoneal cells ( Figure 5C ). These in vivo experiments are consistent with our in vitro finding that caveolin-1 plays a critical role in monocyte to macrophage differentiation. Figure 5 . Caveolin-1 knockout (KO) mice display lower monocyte to macrophage differentiation. A, Peritoneal cells were isolated from wild-type (WT) and caveolin-1 KO mice with or without thioglycollate injection. PE-CD115 or PE-F4/80 antibodies were applied with allophycocyanin (APC)-CD11b antibodies to detect the isolated cells by flow cytometry. The dots gated by square frames in representative flow analysis are macrophages (CD115 and F4/80). The bar graphs group the percentage of gated cells (*P<0.05; n=8-9). B and C, Peritoneal cells were isolated from injected mice (WT and KO). B, Proteins in nuclear fraction (NP) and whole cell lysate (WCL) were detected by Western blot. Bar graphs display the ratios of EGR-1 in NP to WCL fraction and phosphorylated extracellular signal-related kinase (ERK) to total ERK, respectively (*P<0.05; n=6). C, Graph shows the relative quantitative ratio of EGR-1 binding sequence on CD115 promoter in precipitated group to input group, and anti-EGR-1 antibody precipitated group in KO mice is set as 1. Rabbit IgG was applied to exclude the nonspecific antibody binding ( * P<0.05; n=6). pERK indicates phosphorylated ERK; t-ERK, total ERK.
Discussion
Monocyte to macrophage differentiation is a pivotal step in the pathogenesis of atherosclerosis, culminating in the formation of foam cells in atherosclerotic lesions. 2, 23 In this study, we show for the first time that caveolin-1 plays a critical role in the ability of monocytes to differentiate into macrophages through phosphorylation of ERK and EGR-1 nuclear translocation in vitro and in vivo. Consistent with this, we also show that caveolin-1 is critical for normal macrophage function, inhibiting cellular transmigration but promoting phagocytosis and that KO or knockdown of caveolin-1 decreases modified LDL uptake and lipid content, consistent with the inhibition of foam cell formation. These findings suggest that monocytic caveolin-1 may be a novel therapeutic target for atherosclerosis.
THP-1 monocytes are widely used as a cell model to study monocyte differentiation into macrophages. [16] [17] [18] Distinct from other monocytic cell lines, 24 increased caveolin-1 was found in PMA-treated, differentiated THP-1 cells compared with undifferentiated ones, a finding validated in human and mouse primary monocytes in the current study. Because a high correlation (0.78 or 0.84 correlation coefficient) has been reported 25 to exist between THP-1 and primary monocytes, or between PMA-induced THP-1 macrophages and human monocytederived macrophages, we have continued to use THP-1 cells as a representative of the primary cells in the majority of our in vitro experiments, validating key findings in primary cells (both human and mouse).
The differentiation of monocytes into macrophages is dependent on a developmentally ordered pattern of gene expression regulated by several transcription factors, such as PU.1, C/EBPa, AML1, EGR-1, MafB, and IRF-8/ICSBP. 15 Through gain-in-function or knockdown strategies, EGR-1 is the unique factor reported to affect only cells of monocyte/ macrophage lineage, not other hematopoietic cells. 21, 26 During differentiation, EGR-1 is activated to increase CD115 expression on monocytes, promoting M-CSF signaling. 27 In order to exert their effect, transcription factors need to translocate into nucleus after synthesis in the endoplasmic reticulum. It is known that EGR-1 nuclear translocation is dependent on ERK activation. 28 In the current study, we show that knockdown or KO of caveolin-1 inhibits ERK phosphorylation, thus, impairing EGR-1 nuclear translocation and reducing its transcriptional activity. Caveolin-1 may also affect integrin signaling and other transcriptional factors, which are also related to monocyte differentiation to macrophage. For example, the β2-integrin family of receptors has been reported to be involved in monocyte to macrophage differentiation. 29, 30 Because caveolin-1 has been demonstrated to regulate β1-integrin signaling, 31 we can speculate that caveolin-1 also modulates β2-integrins to influence differentiation. Also, as the transcription factor IRF-8/ICSBP has been identified as a regulator of macrophage maturation 32 and caveolin-1 has been reported to influence its activation through the Janus kinase/signal transducers and activators of transcription signal pathway, 33 this may be another means by which caveolin-1 influences differentiation.
Monocyte-derived macrophages are a key component of foam cell formation, a major cellular fraction in atherosclerotic lesions 23 where LDL is taken up by macrophages which accumulate intracellular lipids. 34 We report that knockdown or KO of caveolin-1 attenuated phagocytosis and acetylated LDL uptake and that LDL-induced lipid accumulation was limited in caveolin-1 KO cells compared with wild-type macrophages. We also show that phagocytosis by macrophages was reduced by caveolin-1 knockdown. 8, 11 These findings are consistent with the premise that caveolin-1 is involved in monocyte to macrophage differentiation and the functional effects of macrophages. CD36 and scavenger receptor class B type I (SR-BI), the 2 key molecules involved in LDL uptake, are colocalized with caveolin-1 together on the cell surface, and caveolin-1 deficiency can disrupt the plasmamembrane location and dysfunction CD36 or SR-BImediated lipid endocytosis. 8, 24 As shown in Figure 2A -2B, CD36 was observed to increase after PMA-induced differentiation and attenuated by knockdown of caveolin-1 during differentiation implying that CD36 may be involved in the differentiation-increased modified LDL endocytosis ( Figure 4C ; and Figure IVA in the online-only Data Supplement). Cholesterol and fatty acid in lipoproteins are taken up by macrophages and then metabolized into cholesteryl esters and triglycerides stored in cells. 35 Once loaded, macrophages turn into foam cells. 34 Thus, intracellular cholesteryl esters and triglycerides can be used as markers of foam cell formation. In the current study, we scanned the global profile of free cholesterol, cholesteryl esters, and triglycerides amounts ( Table  III in the online-only Data Supplement) in LDL-treated cells and found that KO of caveolin-1 reduces the accumulation of cholesteryl ester and triglycerides in cells. However, there was no significant effect on free cholesterol, a major membrane constitute, after LDL loading in both WT and KO cells (data not shown). These findings suggest that caveolin-1 is associated with foam cell formation and that inhibiting monocyte/ macrophage caveolin-1 is likely to decrease foam cell formation, potentially diminishing atherosclerotic lesion formation.
To demonstrate that the in vitro findings are physiologically relevant, we performed a series of experiments using the caveolin-1 KO mouse. Here, we report that monocyte to macrophage differentiation was attenuated in caveolin-1 KO mice. The process of monocyte to macrophage differentiation originates from progenitor monocytes in bone marrow to blood monocytes differentiating into macrophages in peripheral tissues (for example in the peritoneal cavity). Under normal conditions, no significant difference was observed on the quantity of peritoneal mature macrophages 36 (CD11b + /F4/80 + cells) between WT and KO. CD115, a marker of mononuclear phagocytes system and which is regulated at early stages of differentiation, 37 however, was significantly reduced in KO mice. When thioglycollate, which induces peritonitis, was introduced, peritoneal macrophages were observed to increase, as expected, in WT mice. In contrast, this increase was not observed in KO mice, substantiating our in vitro observations that caveolin-1 is involved in monocyte to macrophage differentiation. Concurrently, we also observed that monocyte levels were higher in peripheral blood from KO mice compared with WT, consistent with the low conversion of monocytes to macrophages in these animals. These levels were not affected by thioglycollate, which as described above had no effect on monocyte to macrophage conversion in these animals. This supposition is substantiated by the finding that the percentage ratio of peritoneal macrophages to blood monocytes is 2.46 (27%/11%) in WT compared with 1.58 (30%/19%) in KO mice. Also, WT mice were observed to have higher levels of bone marrow-derived monocytes than KO animals, which may be because of the higher demand to replenish peripheral monocytes in these animals. After thioglycollate injection, a fall in bone marrow monocytes in the WT mice was observed possibly because of immediate mobilization of these cells into the periphery. Moreover, hematopoietic caveolin-1 has been demonstrated to be involved in immune modulation, as KO of caveolin-1 promotes regulatory T lymphocyte generation decreasing atherosclerosis in apoE mice. 38 As human CD4 + CD25 + regulatory T cells can exert suppressive effects on monocytes or macrophages, 39 these T cells may be involved in the effects of caveolin-1 on monocyte differentiation.
The implications of the current findings are pronounced. Caveolin-1 is expressed constitutively in various cells, including endothelial cells, smooth muscle cells, and monocytes/ macrophages, all of which are involved in atherogenesis. The roles of caveolin-1 in each of these cell types may be different. Caveolin-1 in the endothelium mediates lipid uptake and inhibits NO phosphorylation, thus, exerting a proatherosclerotic influence. [40] [41] [42] Caveolin-1-deficient aortic smooth muscle cells display an increase in cell proliferation, migration, and endothelin-induced signal transduction implying that in smooth muscle cells caveolin-1 has an antiatherosclerotic function. 43 The current study demonstrates that caveolin-1 mediates monocyte differentiation into macrophage while also influencing macrophage endocytosis of lipids, both essential steps for the formation of macrophage-derived foam cells. Interestingly, this is reflected in caveolin-1 and apoE double KO mice, which display a proatherogenic lipoprotein profile, despite the fact that atherosclerotic lesions are smaller when compared with apoE KO mice. 44 Specific cellular downregulation of caveolin-1, therefore, appears to be 1 potential way forward toward future therapeutic benefits.
In conclusion, we report for the first time that caveolin-1 is a critical regulator of monocyte differentiation into macrophage and as such that targeted inhibition of monocytic caveolin-1 may impair differentiation and hence reduce atherosclerosis.
